Home pageCRL • NYSE
add
Charles River Laboratories International, Inc.
106,05Â $
After Hours:(0,0094%)-0,010
106,04Â $
Data e ora chiusura: 17 apr, 18:00:25 GMT-4 · USD · NYSE · Disclaimer
Chiusura precedente
104,25Â $
Intervallo giornaliero
102,65Â $ - 106,23Â $
Intervallo annuale
91,86Â $ - 254,15Â $
Cap di mercato
5,21Â Mld USD
Volume medio
1,91Â Mln
Rapporto P/E
531,71
Dividendo/Prezzo
-
Borsa valori principale
NYSE
Notizie
Dati finanziari
Conto economico
Entrate
Utile netto
(USD) | dic 2024info | Variazione Y/Y |
---|---|---|
Entrate | 1,00Â Mld | -1,08% |
Spese di gestione | 235,66Â Mln | 3,20% |
Utile netto | -214,50Â Mln | -214,65% |
Margine di profitto netto | -21,39 | -215,87% |
Utili per azione | 2,66 | 8,13% |
EBITDA | 170,83Â Mln | -17,24% |
Aliquota fiscale effettiva | 1,40% | — |
Stato patrimoniale
Totale attivo
Totale passivo
(USD) | dic 2024info | Variazione Y/Y |
---|---|---|
Investimenti cash/breve termine | 194,61Â Mln | -29,69% |
Totale attivo | 7,53Â Mld | -8,13% |
Totale passivo | 4,02Â Mld | -11,37% |
Patrimonio netto totale | 3,51 Mld | — |
Azioni in circolazione | 51,14 Mln | — |
Prezzo/valore contabile | 1,54 | — |
Redditività dell'attivo | 2,51% | — |
Rendimento sul capitale | 3,03% | — |
Flusso di cassa
Flusso di cassa netto
(USD) | dic 2024info | Variazione Y/Y |
---|---|---|
Utile netto | -214,50Â Mln | -214,65% |
Liquidità di esercizio | 159,36 Mln | -27,87% |
Contanti da investimenti | -76,10Â Mln | 68,07% |
Contanti da finanziamenti | -75,88Â Mln | -161,41% |
Flusso di cassa netto | -6,07Â Mln | -105,11% |
Flusso di cassa libero | 69,58Â Mln | 82,32% |
Informazioni
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry and offers support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe. The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories is often criticized by animal rights activists, who condemn the company's use of dogs and non-human primates for pharmaceutical research. The company is also a major harvester of blood from horseshoe crabs. Wikipedia
Fondazione
1947
Sito web
Dipendenti
19.400